Fotopresentatie Mensink Berndes, Het Rabelink 18, Breedenbroek
Voorgestelde werkingsmechanismen - state of the art - Ronald P. Mensink Maastricht University,...
-
Upload
lindsey-powell -
Category
Documents
-
view
219 -
download
1
Transcript of Voorgestelde werkingsmechanismen - state of the art - Ronald P. Mensink Maastricht University,...
Voorgestelde werkingsmechanismen
- state of the art -
Ronald P. Mensink
Maastricht University, Department of Human Biology
School of Nutrition, Toxicology, and Metabolism (NUTRIM)
Some considerations
• Most studies are observational
• Intervention studies on low-fat
dairy are scarce
• Main research question:
What are the effects of low-fat dairy products
on metabolic risk markers in subjects at
increased risk of metabolic disorders?
Why the metabolic syndrome
Abdominal obesity
Insulinresistance
Elevated blood pressure
Pro-inflammatory
state
Atherogenicdyslipidemia
Pro-thrombotic
state
CVDDiabetes Mellitus
Measurements
• Blood sampling:
Week 0, 4, 7, 8
• Blood pressure
• Body weight
Abdominal obesity
Insulinresistance
Elevated blood pressure
Pro-inflammatory
state
Atherogenicdyslipidemia
Pro-thrombotic
state
SubjectsBaseline characteristics
Men / women 10 / 25
Age (y) 49.5 ± 13.2
BMI (kg/m2) 32.0 ± 3.8
Systolic BP (mmHg) 135 ± 19.9
Diastolic BP (mmHg) 88 ± 13.2
Total cholesterol (mmol/L) 6.06 ± 1.0
HDL cholesterol (mmol/L) 1.40 ± 0.4
LDL cholesterol (mmol/L) 4.04 ± 1.0
Triglycerides (mmol/L) 1.36 ± 0.5
Glucose (mmol/L) 5.68 ± 0.6
Study design
40 overweight or obese subjects• BMI > 27 kg/m2 and/or waist > 102 cm (men) or 88 cm (women)
• Low dairy intake (< 500 g)
Group Period 1
(8 wk)
Wash out
(2 wk)
Period 2
(8 wk)
A Low-fat dairy Control
B Control Low-fat dairy
T0 4 7 8 0 4 7 8
Dietary intervention
Dairy
500 mL low-fat milk
150 g low-fat yogurt
375 kcal
24.4 g
43.6 g
9.8 g
800 mg
Control
600 mL fruit juice
3 fruit biscuits
400 kcal
2.4 g
89.6 g
3.9 g
-
Energy
Protein
Carbohydrates
Fat
Calcium
110
120
130
Decrease in 1,25-(OH)2-Vitamin D3 (calcitriol) Confirmed Compliance
• Calcium intake depresses calcitriol levels• Used as compliance marker
*
* P < 0.05
pm
ol/L
Control
Low-fat dairy
= 8.7 pmol/L
120
125
130
135
80
85
90
Low-fat Dairy Decreased Systolic, but not Diastolic, Blood Pressure
mm
Hg
Control
= 2.9 mm Hgp=0.027
mm
Hg
Low-fat dairy
Systolic
= 1.6 mm Hgp=0.090
Diastolic
80
85
90
Results when 10 Subjects on Anti-Hypertensive Medication are Excluded
120
125
130
135
mm
Hg
Control
mm
Hg
Low-fat dairy
= 4.2 mm Hgp=0.010
Systolic
= 1.8 mm Hgp=0.055
Diastolic
Conclusion
Consumption of low-fat dairy for 8 weeks does lower systolic blood pressure in
overweight subjects
-6
-4
-2
0
2
Q 1 Q 2 Q 3 Q 4 Q 5
(m
m H
g)
Changes in Systolic BP After 1 Yr of Changes in Systolic BP After 1 Yr of Follow-up are Related to Low-Fat, but Follow-up are Related to Low-Fat, but Not to High-Fat Dairy, ConsumptionNot to High-Fat Dairy, Consumption
Low-fat Dairy High-Fat DairyToledo E et al. Br J Nutr, 2008
P for trend, Low-Fat: 0.01High-fat: 0.84
*
*
-6
-4
-2
0
2
Q 1 Q 2 Q 3 Q 4 Q 5
(mm
Hg)
Changes in Diastolic BP After 1 Yr of Changes in Diastolic BP After 1 Yr of Follow-up are Related to Low-Fat, but Follow-up are Related to Low-Fat, but Not to High-Fat Dairy, ConsumptionNot to High-Fat Dairy, Consumption
Low-fat Dairy High-Fat DairyToledo E et al. Br J Nutr, 2008
P for trend, Low-Fat: 0.09High-fat: 0.61
*
Flow-Mediated Dilatation is Flow-Mediated Dilatation is Impaired by Saturated Fatty AcidsImpaired by Saturated Fatty Acids
Keogh JN et al. ATVB, 2005
But ...
• Effects of low-fat vs. high-fat dairy products are not consistent
• Many studies have shown that total or saturated fat intake is not a determinant of blood pressure
Total Fat Intake Has No Effect on Total Fat Intake Has No Effect on Systolic and Diastolic BPSystolic and Diastolic BP
-6
-4
-2
0
2
0 1 2 3 4 5 6
6 mo 12 mo 6 mo 12 moSystolic Diastolic
(m
m H
g)
+ Low-carb
Nordmann AJ et al. Arch Intern Med, 2006
50
70
90
110
130
Systolic Diastolic
mm
Hg
CLA and Vaccenic Acid Have No Effect CLA and Vaccenic Acid Have No Effect on Blood Pressureon Blood Pressure
CLA Vaccenic acid ControlRaft M et al. J Nutr, 2006
CLA and Vaccenic Acid Have No Effect CLA and Vaccenic Acid Have No Effect on Arterial Functionon Arterial Function
Raft M et al. J Nutr, 2006
• Arterial compliance did not change
Conclusion- Fat -
• The amount or composition of fat in dairy products cannot be responsible for the relationship between dairy consumption and blood pressure
A Mixture of Animal and Vegetable Protein A Mixture of Animal and Vegetable Protein Lowers BP Compared with CarbohydratesLowers BP Compared with Carbohydrates
-4
-2
0
All Pre-HT HT All Pre-HT HTSystolic Diastolic
(m
m H
g)
Appel LJ et al. JAMA, 2005 Protein Unsaturated Fat
Peptides from Milk Proteins May Have ACE-Inhibiting Properties
• Val-Pro-Pro
Valine-Proline-Proline
• Ile-Pro-Pro
Isoleucine-Proline-Proline
Isoleucine Valine Proline
The Role of ACE (Angiotensin Converting Enzyme) in Blood Pressure Regulation
Angiotensinogen in plasma
ANG I in plasma
ANG II in plasma
Renin
ACE
Blood pressure
In Vitro and Animal Studies Have Shown that Tripeptides Lower ACE-activity
Sipola M. J Physiol Pharmacol, 2001
Control
Tripeptide
Fermented milkLactobacillushelveticus
Design
• Parallel-design with two groups• 39 hypertensive subjects• 21 weeks• 2.0 mg Val-Pro-Pro per 100 g• 1.5 mg Ile-Pro-Pro per 100 g• Daily intake: 150 mL fermented milk• Measurement taken at home by the subject
Seppo L et al. Am J Clin Nutr, 2003
Seppo L et al. Am J Clin Nutr, 2003
A Fermented Milk High in Peptides Lowers Human Blood Pressure
-20
-15
-10
-5
0
(mm
Hg)
Intervention Control
P=0.059
P=0.030
Systolic Diastolic
Design
• Parallel-design with four groups• 134 subjects with elevated SBP• 8 weeks• 2.0 mg Val-Pro-Pro per 100 g• 2.6 mg Ile-Pro-Pro per 100 g• Daily intake: 200 mL yogurt• Measurements taken at home by the subject
Engberink MF et al. Hypertension, 2008
The Four Treatments
• Control• Fermented lactotripeptides• Enzymatic lactotripeptides• Synthetic lactotripeptides
Engberink MF et al. Hypertension, 2008
Engberink MF et al. Hypertension 2008
Lactotripeptides Did not Change ACE-activity and Angiotensin II
-0,4
-0,2
0,0
0,2
0,4
-4
-2
0
U/L
Control
pm
ol/L
FermentedLTP
ACE-activity Angiotensin II
EnzymaticLTP
SyntethicLTP
Conclusion- Protein / Bioactive peptides -
• Protein may lower blood pressure compared with carbohydrates
• There is no unequivocal evidence that tripeptides (Ile-Pro-Pro or Val-Pro-Pro) lower human blood pressure
Calcium may lower blood pressure
• Several meta-analyses have suggested an effect of dietary calcium on in particular systolic blood pressure
• This effect may diminish at higher intakes and depend on genetic background
• Is the effect of dietary sources stronger than that of supplements?
Why does dietary calcium lower BP- Zemel Hypothesis -
Dietary calcium
Intracellularcalcium
1,25-(OH)2-D
Vascularresistance
Blood pressure
Calcium influx
Some Important Implications of the Zemel Hypothesis
• Dietary calcium lowers plasma 1,25-(OH)2-D concentrations
• Dietary calcium lowers intracellular calcium concentrations
• Plasma 1,25-(OH)2-D concentrations are positively related to blood pressure
Some Important Implications of the Zemel Hypothesis
• Dietary calcium lowers plasma 1,25-(OH)2-D concentrations
• Dietary calcium lowers intracellular calcium concentrations
• Plasma 1,25-(OH)2-D concentrations are positively related to blood pressure
Plasma 1,25-(OH)2-D levels are NOT positively related to blood pressure
• An inverse relationship exists between plasma 1,25-(OH)2-D and blood pressure
• Vitamin D treatment lowers blood pressure
• Ultraviolet light may lower blood pressure
• Blood pressure tends to be higher in winter than in summer
• Studies in transgenic animals
Why is Plasma 1,25-(OH)2-D Negatively Related to Blood Pressure?
Hypothesis:
1,25-(OH)2-D lowers renin
expression and activity
Angiotensinogen in plasma
ANG I in plasma
ANG II in plasma
Renin
ACE
Blood pressure
Conclusion- Calcium -
• Calcium is a likely candidate• There is not much support for the Zemel-
hypothesis